Integrity Alliance’s West Pharmaceutical WST Stock Holding History

Integrity Alliance’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$212K	Buy	+572	New	+$202K	0.01%	872

Other funds holding WST

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Integrity Alliance's WST Position: Q3 2026 in Review

Integrity Alliance opened a new position in West Pharmaceutical (WST) in Q3 2026: 572 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #872 among its holdings.

282 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Integrity Alliance held 572 shares of West Pharmaceutical worth $212K as of Q3 2026.
West Pharmaceutical was a new Integrity Alliance position in Q3 2026.
West Pharmaceutical made up 0.01% of Integrity Alliance's portfolio in Q3 2026, its #872 holding.
282 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Integrity Alliance's 13F filing for Q3 2026, filed 29 Oct 2026.